News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.
The researchers have devised an SRM workflow using extensive fractionation and multiple dimensions of separation to measure proteins at picograms per mL levels.
The company posted Q2 revenues of $558.3 million, up from $536.6 million in Q2 2016 and beating the average Wall Street estimate of $553.1 million.
While actual clinical implementation remains distant, MALDI imaging technology has advanced to the point where it might feasibly be applied to pathology.
Waters has obtained a non-exclusive license to the technology, which allows researchers to create internal standard calibration curves for their assays.
Though still on the fringes of life science research, these instruments could be attractive for targeted applications due to their portability and simplicity.
